LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 13, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,867
Total Value
$910,648.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 11, 2026 | Exercise/Conversion | 2,405 | $92.65 | $222,823.25 | 24,067 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 11, 2026 | Sale | 3,057 | $225.00 | $687,825.00 | 21,010 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Mar 11, 2026 | Exercise/Conversion | 2,405 | $0.00 | $0.00 | 0 | Direct | โ | View Details |